Geode Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $220K | Sell |
133,329
-161
| -0.1% | -$266 | ﹤0.01% | 3844 |
|
2025
Q1 | $211K | Sell |
133,490
-1,527
| -1% | -$2.41K | ﹤0.01% | 3834 |
|
2024
Q4 | $452K | Buy |
135,017
+427
| +0.3% | +$1.43K | ﹤0.01% | 3630 |
|
2024
Q3 | $253K | Sell |
134,590
-1,080
| -0.8% | -$2.03K | ﹤0.01% | 3828 |
|
2024
Q2 | $267K | Buy |
135,670
+28,895
| +27% | +$56.9K | ﹤0.01% | 3809 |
|
2024
Q1 | $328K | Buy |
106,775
+12,432
| +13% | +$38.2K | ﹤0.01% | 3768 |
|
2023
Q4 | $220K | Buy |
94,343
+66,809
| +243% | +$156K | ﹤0.01% | 3907 |
|
2023
Q3 | $110K | Buy |
27,534
+2,589
| +10% | +$10.4K | ﹤0.01% | 4217 |
|
2023
Q2 | $101K | Hold |
24,945
| – | – | ﹤0.01% | 4329 |
|
2023
Q1 | $76.8K | Sell |
24,945
-4
| -0% | -$12 | ﹤0.01% | 4423 |
|
2022
Q4 | $67K | Sell |
24,949
-62
| -0.2% | -$166 | ﹤0.01% | 4515 |
|
2022
Q3 | $100K | Hold |
25,011
| – | – | ﹤0.01% | 4579 |
|
2022
Q2 | $175K | Sell |
25,011
-1,125
| -4% | -$7.87K | ﹤0.01% | 4352 |
|
2022
Q1 | $305K | Hold |
26,136
| – | – | ﹤0.01% | 4173 |
|
2021
Q4 | $479K | Hold |
26,136
| – | – | ﹤0.01% | 4070 |
|
2021
Q3 | $653K | Buy |
26,136
+214
| +0.8% | +$5.35K | ﹤0.01% | 3902 |
|
2021
Q2 | $1.64M | Sell |
25,922
-14,613
| -36% | -$923K | ﹤0.01% | 3356 |
|
2021
Q1 | $4.99M | Buy |
40,535
+8,487
| +26% | +$1.05M | ﹤0.01% | 2789 |
|
2020
Q4 | $3.65M | Buy |
32,048
+1,806
| +6% | +$205K | ﹤0.01% | 2763 |
|
2020
Q3 | $3.61M | Buy |
30,242
+5,089
| +20% | +$608K | ﹤0.01% | 2576 |
|
2020
Q2 | $3.13M | Buy |
25,153
+18,583
| +283% | +$2.31M | ﹤0.01% | 2594 |
|
2020
Q1 | $1.27M | Buy |
6,570
+4,766
| +264% | +$919K | ﹤0.01% | 2912 |
|
2019
Q4 | $602K | Buy |
1,804
+83
| +5% | +$27.7K | ﹤0.01% | 3445 |
|
2019
Q3 | $555K | Buy |
1,721
+3
| +0.2% | +$967 | ﹤0.01% | 3439 |
|
2019
Q2 | $740K | Buy |
1,718
+479
| +39% | +$206K | ﹤0.01% | 3327 |
|
2019
Q1 | $700K | Buy |
1,239
+67
| +6% | +$37.9K | ﹤0.01% | 3302 |
|
2018
Q4 | $347K | Buy |
1,172
+50
| +4% | +$14.8K | ﹤0.01% | 3497 |
|
2018
Q3 | $795K | Buy |
1,122
+167
| +17% | +$118K | ﹤0.01% | 3310 |
|
2018
Q2 | $558K | Buy |
955
+54
| +6% | +$31.6K | ﹤0.01% | 3397 |
|
2018
Q1 | $2.44M | Buy |
+901
| New | +$2.44M | ﹤0.01% | 2656 |
|